pyrroles has been researched along with Animal Mammary Carcinoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biasato, I; Buracco, P; De Maria, R; Gattino, F; Gola, C; Iussich, S; Maniscalco, L; Martano, M; Martín de Las Mulas, J; Millán Ruiz, Y; Morello, E; Saeki, N | 1 |
| Marconato, L; Rossi, F; Sabattini, S; Vascellari, M | 1 |
| Du, Y; Fang, J; Guo, X; Jin, Y; Liang, X; Lu, W; Sun, W; Tian, J; Yu, C; Zheng, J | 1 |
| Brearley, M; Dobson, J; Marcinowska, A; Warland, J | 1 |
| Kamaike, K; Kashiwagi, K; Kawashima, E; Nakanishi, Y; Ohba, Y; Terui, Y; Tomitori, H | 1 |
| Abe, F; Dafferner, A; Hoke, TA; Samson, H; Scholar, E; Talmadge, JE; Westphal, S; Younos, I | 1 |
| Belisario, DC; Bolli, E; Bosia, A; Calogero, RA; Cavallo, F; Pinto, H; Riganti, C | 1 |
7 other study(ies) available for pyrroles and Animal Mammary Carcinoma
| Article | Year |
|---|---|
PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.
Topics: Animals; Cell Line, Tumor; Dog Diseases; Dogs; Female; Indoles; Mammary Neoplasms, Animal; Proto-Oncogene Proteins c-kit; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Vascular Endothelial Growth Factor Receptor-2 | 2018 |
The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Indoles; Mammary Neoplasms, Animal; Neoplasm Staging; Piroxicam; Pyrroles; Radiation Dose Hypofractionation; Thalidomide; Treatment Outcome | 2018 |
Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer.
Topics: Animals; Camptothecin; Cell Line, Tumor; Combined Modality Therapy; Female; Fluorescence; Hyaluronic Acid; Hyperthermia, Induced; Immunity; Immunotherapy; Mammary Neoplasms, Animal; Mice; Nanoparticles; Neoplasm Metastasis; Neoplasm Recurrence, Local; Optical Imaging; Photoacoustic Techniques; Phototherapy; Polymers; Pyrroles; Tissue Distribution | 2019 |
A novel approach to treatment of lymphangiosarcoma in a boxer dog.
Topics: Animals; Antibiotics, Antineoplastic; Dog Diseases; Dogs; Doxorubicin; Female; Indoles; Lymphangiosarcoma; Mammary Glands, Animal; Mammary Neoplasms, Animal; Neoplasm Recurrence, Local; Pyrroles; Survival Rate; Treatment Outcome | 2013 |
Synthesis and evaluation of pyrrole polyamide-2'-deoxyguanosine 5'-phosphate hybrid.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Deoxyguanine Nucleotides; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Animal; Mice; Molecular Structure; Neoplasms; Nylons; Pyrroles | 2013 |
Therapeutic activity of sunitinib for Her2/neu induced mammary cancer in FVB mice.
Topics: Animals; Antigens, CD; Antineoplastic Agents; Disease Progression; Female; Immune Evasion; Indoles; Mammary Neoplasms, Animal; Mice; Mice, Inbred Strains; Mice, Transgenic; Myeloid Cells; Pyrroles; Receptor, ErbB-2; Sunitinib; T-Lymphocytes, Regulatory | 2010 |
Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer.
Topics: Animals; Antineoplastic Agents; Atorvastatin; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Hypolipidemic Agents; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 6; Neoplasms, Experimental; NF-kappa B; Pyrroles; ras Proteins; Receptor, ErbB-2; rhoA GTP-Binding Protein; Terpenes | 2011 |